This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services E-mail this article to a friend Similar articles in this journal Similar articles in ASM journals Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Ednie, L. M. Articles by Appelbaum, P. C. Search for Related Content PubMed PubMed Citation Articles by Ednie, L. M. Articles by Appelbaum, P. C.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, Aug 1996, 1950-1952, Vol 40, No. 8
Copyright © 1996 by the American Society for Microbiology. All rights reserved.

Comparative activities of clarithromycin, erythromycin, and azithromycin against penicillin-susceptible and penicillin-resistant pneumococci

LM Ednie, MA Visalli, MR Jacobs and PC Appelbaum
Department of Pathology (Clinical Microbiology), Hershey Medical Center, Pennsylvania 17033, USA.

Activities of clarithromycin, erythromycin, and azithromycin against 120 pneumococci from the United States were tested by agar dilution MIC. All three compounds yielded MICs at which 90% of the isolates were inhibited (MIC90S) of < or = 0.125 micrograms/ml against penicillin- susceptible and -intermediate strains, but MIC90S against resistant strains were > 128.0 micrograms/ml. All erythromycin-resistant strains were also resistant to clarithromycin and azithromycin. Clarithromycin yielded MICs which were generally one or two dilutions lower than those of the other two compounds for all strains. The respective bacteriostatic and bactericidal values (micrograms per milliliter) for two susceptible, two intermediate, and two resistant strains were 0.004 to 0.03 and 0.016 to 0.03 (0.004 to 0.03/0.016 to 0.03) (clarithromycin), 0.008 to 0.06/0.016/0.016 to 0.125 (erythromycin), and 0.016 to 0.06/0.03 to 0.125 (azithromycin); clarithromycin yielded the lowest values. All compounds were uniformly bactericidal after 24 h only; erythromycin was bactericidal at eight times the MIC, and azithromycin and clarithromycin were both bactericidal at two time the MIC. The relevance of these in vitro differences requires clarification by clinical trials.

This article has been cited by other articles:

• Heffelfinger, J. D., Dowell, S. F., Jorgensen, J. H., Klugman, K. P., Mabry, L. R., Musher, D. M., Plouffe, J. F., Rakowsky, A., Schuchat, A., Whitney, C. G., and the Drug-Resistant Streptococcus pneumoniae Th, (2000). Management of Community-Acquired Pneumonia in the Era of Pneumococcal Resistance: A Report From the Drug-Resistant Streptococcus pneumoniae Therapeutic Working Group. Arch Intern Med 160: 1399-1408 [Abstract] [Full Text]  
• Dagan, R., Leibovitz, E., Fliss, D. M., Leiberman, A., Jacobs, M. R., Craig, W., Yagupsky, P. (2000). Bacteriologic Efficacies of Oral Azithromycin and Oral Cefaclor in Treatment of Acute Otitis Media in Infants and Young Children. Antimicrob. Agents Chemother. 44: 43-50 [Abstract] [Full Text]  
• Verhaegen, J., Verbist, L. (1999). In-vitro activities of 16 non-{beta}-lactam antibiotics against penicillin-susceptible and penicillin-resistant Streptococcus pneumoniae. J Antimicrob Chemother 43: 563-567 [Abstract] [Full Text]  
• Pankuch, G. A., Jueneman, S. A., Davies, T. A., Jacobs, M. R., Appelbaum, P. C. (1998). In Vitro Selection of Resistance to Four beta -Lactams and Azithromycin in Streptococcus pneumoniae. Antimicrob. Agents Chemother. 42: 2914-2918 [Abstract] [Full Text]